{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:17:31Z","timestamp":1771424251550,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foshan Science and Technology Innovation Project","award":["2420001003774"],"award-info":[{"award-number":["2420001003774"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-07842-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T18:56:29Z","timestamp":1769540189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-density lipoprotein (HDL) in older patients with schizophrenia: implications for clinical and cognitive outcomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Shuyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaquan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhencheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangcheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"5","key":"7842_CR1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamapsychiatry.2021.0015","volume":"78","author":"K Hagi","year":"2021","unstructured":"Hagi K, Nosaka T, Dickinson D, Lindenmayer JP, Lee J, Friedman J, Boyer L, Han M, Abdul-Rashid NA, Correll CU. Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: A systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(5):510\u20138.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"7842_CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/YCO.0000000000000694","volume":"34","author":"HV Solomon","year":"2021","unstructured":"Solomon HV, Sinopoli M, DeLisi LE. Ageing with schizophrenia: an update. Curr Opin Psychiatry. 2021;34(3):266\u201374.","journal-title":"Curr Opin Psychiatry"},{"key":"7842_CR3","doi-asserted-by":"crossref","first-page":"1081620","DOI":"10.3389\/fpsyt.2022.1081620","volume":"13","author":"C Wu","year":"2022","unstructured":"Wu C, Ye J, Li S, Wu J, Wang C, Yuan L, Wang H, Pan Y, Huang X, Zhong X, et al. Predictors of everyday functional impairment in older patients with schizophrenia: A cross-sectional study. Front Psychiatry. 2022;13:1081620.","journal-title":"Front Psychiatry"},{"issue":"2","key":"7842_CR4","doi-asserted-by":"crossref","first-page":"100006","DOI":"10.1016\/j.inpsyc.2024.100006","volume":"37","author":"AC Golas","year":"2025","unstructured":"Golas AC, Elgallab BM, Abdool PS, Bowie CR, Rajji TK. Cognitive remediation for patients with late-life schizophrenia: A follow-up pilot study. Int Psychogeriatr. 2025;37(2):100006.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"7842_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12888-017-1530-9","volume":"17","author":"C Ban","year":"2017","unstructured":"Ban C, Zhang Q, Feng J, Li H, Qiu Q, Tian Y, Li X. Low prevalence of lipid metabolism abnormalities in APOE \u03b52-genotype and male patients 60 years or older with schizophrenia. BMC Psychiatry. 2017;17(1):399.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"7842_CR6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bdi.12294","volume":"17","author":"S Bonaccorso","year":"2015","unstructured":"Bonaccorso S, Sodhi M, Li J, Bobo WV, Chen Y, Tumuklu M, Theleritis C, Jayathilake K, Meltzer HY. The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia. Bipolar Disord. 2015;17(5):528\u201335.","journal-title":"Bipolar Disord"},{"issue":"1","key":"7842_CR7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.9758\/cpn.2023.21.1.68","volume":"21","author":"M Kim","year":"2023","unstructured":"Kim M, Yang SJ, Kim HH, Jo A, Jhon M, Lee JY, Ryu SH, Kim JM, Kweon YR, Kim SW. Effects of dietary habits on general and abdominal obesity in Community-dwelling patients with schizophrenia. Clin Psychopharmacol Neuroscience: Official Sci J Korean Coll Neuropsychopharmacol. 2023;21(1):68\u201376.","journal-title":"Clin Psychopharmacol Neuroscience: Official Sci J Korean Coll Neuropsychopharmacol"},{"issue":"1","key":"7842_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acsami.2c02940","volume":"15","author":"J Huang","year":"2023","unstructured":"Huang J, Zhu H, Yu P, Ma Y, Gong J, Fu Y, Song H, Huang M, Luo J, Jiang J, et al. Recombinant High-Density lipoprotein boosts the therapeutic efficacy of mild hypothermia in traumatic brain injury. ACS Appl Mater Interfaces. 2023;15(1):26\u201338.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"7","key":"7842_CR9","doi-asserted-by":"crossref","first-page":"100577","DOI":"10.1016\/j.jlr.2024.100577","volume":"65","author":"J Wang","year":"2024","unstructured":"Wang J, Kockx M, Bolek M, Lambert T, Sullivan D, Chow V, Kritharides L. Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII, and E in patients with schizophrenia. J Lipid Res. 2024;65(7):100577.","journal-title":"J Lipid Res"},{"key":"7842_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neubiorev.2021.06.017","volume":"128","author":"G Morris","year":"2021","unstructured":"Morris G, Berk M, Walder K, O\u2019Neil A, Maes M, Puri BK. The lipid paradox in neuroprogressive disorders: causes and consequences. Neurosci Biobehav Rev. 2021;128:35\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"7842_CR11","doi-asserted-by":"crossref","unstructured":"Sapienza J, Agostoni G, Repaci F, Spangaro M, Comai S, Bosia M. Metabolic syndrome and schizophrenia: adding a piece to the interplay between the kynurenine pathway and inflammation. Metabolites. 2025;15(3).","DOI":"10.3390\/metabo15030176"},{"key":"7842_CR12","doi-asserted-by":"crossref","unstructured":"K\u0131l\u0131\u00e7 N, Tasci G, Y\u0131lmaz S, \u00d6ner P, Korkmaz S. Monocyte\/HDL cholesterol ratios as a new inflammatory marker in patients with schizophrenia. J Personalized Med. 2023;13(2).","DOI":"10.3390\/jpm13020276"},{"issue":"1","key":"7842_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00406-019-01017-w","volume":"270","author":"PB Gjerde","year":"2020","unstructured":"Gjerde PB, Simonsen CE, Lagerberg TV, Steen NE, Ueland T, Andreassen OA, Steen VM, Melle I. Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients. Eur Arch Psychiatry Clin NeuroSci. 2020;270(1):49\u201358.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"key":"7842_CR14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.clinph.2024.03.013","volume":"162","author":"J Sapienza","year":"2024","unstructured":"Sapienza J, Pacchioni F, Spangaro M, Bosia M. Dysconnection in schizophrenia: filling the Dots from old to new evidence. Clin Neurophysiology: Official J Int Federation Clin Neurophysiol. 2024;162:226\u20138.","journal-title":"Clin Neurophysiology: Official J Int Federation Clin Neurophysiol"},{"issue":"1","key":"7842_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12872-023-03327-3","volume":"23","author":"D Fentie","year":"2023","unstructured":"Fentie D, Yibabie S. Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, ethiopia: neglected public health concern. BMC Cardiovasc Disord. 2023;23(1):298.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"7842_CR16","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1017\/S0033291717003932","volume":"48","author":"E Bora","year":"2018","unstructured":"Bora E, Akdede BB, Alptekin K. The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis - CORRIGENDUM. Psychol Med. 2018;48(7):1224.","journal-title":"Psychol Med"},{"issue":"4","key":"7842_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000512082","volume":"80","author":"M Bosia","year":"2021","unstructured":"Bosia M, Spangaro M, Sapienza J, Martini F, Civardi S, Buonocore M, Bechi M, Lorenzi C, Cocchi F, Bianchi L, et al. Cognition in schizophrenia: modeling the interplay between Interleukin-1\u03b2 C-511T Polymorphism, metabolic Syndrome, and sex. Neuropsychobiology. 2021;80(4):321\u201332.","journal-title":"Neuropsychobiology"},{"issue":"2","key":"7842_CR18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bja.2023.04.031","volume":"131","author":"I Feinkohl","year":"2023","unstructured":"Feinkohl I, Janke J, Slooter AJC, Winterer G, Spies C, Pischon T. Metabolic syndrome and the risk of postoperative delirium and postoperative cognitive dysfunction: a multi-centre cohort study. Br J Anaesth. 2023;131(2):338\u201347.","journal-title":"Br J Anaesth"},{"issue":"1","key":"7842_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41398-024-02847-6","volume":"14","author":"SMA Mehdi","year":"2024","unstructured":"Mehdi SMA, Costa AP, Svob C, Pan L, Dartora WJ, Talati A, Gameroff MJ, Wickramaratne PJ, Weissman MM, McIntire LBJ. Depression and cognition are associated with lipid dysregulation in both a multigenerational study of depression and the National health and nutrition examination survey. Translational Psychiatry. 2024;14(1):142.","journal-title":"Translational Psychiatry"},{"key":"7842_CR20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jpsychires.2021.07.019","volume":"141","author":"M Spangaro","year":"2021","unstructured":"Spangaro M, Martini F, Bechi M, Buonocore M, Agostoni G, Cocchi F, Sapienza J, Bosia M, Cavallaro R. Longitudinal course of cognition in schizophrenia: does treatment resistance play a role? J Psychiatr Res. 2021;141:346\u201352.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7842_CR21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamapsychiatry.2024.2890","volume":"82","author":"L Feber","year":"2025","unstructured":"Feber L, Peter NL, Chiocchia V, Schneider-Thoma J, Siafis S, Bighelli I, Hansen WP, Lin X, Prates-Baldez D, Salanti G, et al. Antipsychotic drugs and cognitive function: A systematic review and network Meta-Analysis. JAMA Psychiatry. 2025;82(1):47\u201356.","journal-title":"JAMA Psychiatry"},{"key":"7842_CR22","doi-asserted-by":"crossref","first-page":"100328","DOI":"10.1016\/j.scog.2024.100328","volume":"38","author":"J Sapienza","year":"2024","unstructured":"Sapienza J, Agostoni G, Comai S, Nasini S, Dall\u2019Acqua S, Sut S, Spangaro M, Martini F, Bechi M, Buonocore M, et al. Neuroinflammation and kynurenines in schizophrenia: impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise. Schizophrenia Res Cognition. 2024;38:100328.","journal-title":"Schizophrenia Res Cognition"},{"issue":"21","key":"7842_CR23","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1001\/jama.285.21.2729","volume":"285","author":"RL Sacco","year":"2001","unstructured":"Sacco RL, Benson RT, Kargman DE, Boden-Albala B, Tuck C, Lin IF, Cheng JF, Paik MC, Shea S, Berglund L. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA. 2001;285(21):2729\u201335.","journal-title":"JAMA"},{"issue":"11","key":"7842_CR24","doi-asserted-by":"crossref","first-page":"e32113","DOI":"10.1016\/j.heliyon.2024.e32113","volume":"10","author":"SM Yu","year":"2024","unstructured":"Yu SM, Chang XJ, Gu YY, Jia XD, Gao XD, Huang JG, Dong JH, Zeng Z. Serum high-density lipoprotein cholesterol levels predict early recurrence and prognosis of intrahepatic cholangiocarcinoma after surgical resection. Heliyon. 2024;10(11):e32113.","journal-title":"Heliyon"},{"issue":"2","key":"7842_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"1","key":"7842_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13854046.2021.1876169","volume":"37","author":"R Raudeberg","year":"2023","unstructured":"Raudeberg R, Karr JE, Iverson GL, Hammar \u00c5. Examining the repeatable battery for the assessment of neuropsychological status validity indices in people with schizophrenia spectrum disorders. Clin Neuropsychol. 2023;37(1):101\u201318.","journal-title":"Clin Neuropsychol"},{"key":"7842_CR27","doi-asserted-by":"crossref","first-page":"102732","DOI":"10.1016\/j.ajp.2021.102732","volume":"62","author":"K Lim","year":"2021","unstructured":"Lim K, Peh OH, Yang Z, Rekhi G, Rapisarda A, See YM, Rashid NAA, Ang MS, Lee SA, Sim K, et al. Large-scale evaluation of the positive and negative syndrome scale (PANSS) symptom architecture in schizophrenia. Asian J Psychiatry. 2021;62:102732.","journal-title":"Asian J Psychiatry"},{"issue":"1","key":"7842_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13011-025-00640-2","volume":"20","author":"K H\u00f8iland","year":"2025","unstructured":"H\u00f8iland K, Raudeberg R, Egeland J. The repeatable battery for the assessment of neuropsychological status (RBANS) and substance use disorders: a systematic review. Subst Abuse Treat Prev Policy. 2025;20(1):12.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"7842_CR29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger T, McCutcheon RA, Vano L, Mizuno Y, Arumuham A, Hindley G, Beck K, Natesan S, Efthimiou O, Cipriani A, et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(1):64\u201377.","journal-title":"Lancet Psychiatry"},{"key":"7842_CR30","doi-asserted-by":"crossref","first-page":"114199","DOI":"10.1016\/j.psychres.2021.114199","volume":"305","author":"S Grot","year":"2021","unstructured":"Grot S, Gigu\u00e8re C, Smine S, Mongeau-P\u00e9russe V, Nguyen DD, Preda A, Potvin S, van Erp TGM. Fbirn, Orban P: converting scores between the PANSS and SAPS\/SANS beyond the positive\/negative dichotomy. Psychiatry Res. 2021;305:114199.","journal-title":"Psychiatry Res"},{"issue":"16","key":"7842_CR31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","volume":"44","author":"A von Eckardstein","year":"2023","unstructured":"von Eckardstein A, Nordestgaard BG, Remaley AT, Catapano AL. High-density lipoprotein revisited: biological functions and clinical relevance. Eur Heart J. 2023;44(16):1394\u2013407.","journal-title":"Eur Heart J"},{"issue":"1","key":"7842_CR32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12937-024-00983-9","volume":"23","author":"H Huang","year":"2024","unstructured":"Huang H, Yang B, Yu R, Ouyang W, Tong J, Le Y. Very high high-density lipoprotein cholesterol May be associated with higher risk of cognitive impairment in older adults. Nutr J. 2024;23(1):79.","journal-title":"Nutr J"},{"key":"7842_CR33","doi-asserted-by":"crossref","unstructured":"Rosales C, Gillard BK, Gotto AM Jr., Pownall HJ. The alcohol-high-density lipoprotein athero-protective axis. Biomolecules. 2020;10(7).","DOI":"10.3390\/biom10070987"},{"issue":"1","key":"7842_CR34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12951-024-03016-z","volume":"22","author":"J Huang","year":"2024","unstructured":"Huang J, Peng Y, Wang X, Gu X, Yi Y, Wang W, He Z, Ma Z, Feng Q, Qi W, et al. Temperature induces brain-intake shift of Recombinant high-density lipoprotein after traumatic brain injury. J Nanobiotechnol. 2024;22(1):769.","journal-title":"J Nanobiotechnol"},{"key":"7842_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neubiorev.2021.02.037","volume":"125","author":"G Morris","year":"2021","unstructured":"Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, Moreira EG, Maes M. The role of high-density lipoprotein cholesterol, Apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci Biobehav Rev. 2021;125:244\u201363.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"7842_CR36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00325481.2021.2006514","volume":"134","author":"Z Ansari","year":"2022","unstructured":"Ansari Z, Pawar S, Seetharaman R. Neuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing? Postgrad Med. 2022;134(2):187\u201399.","journal-title":"Postgrad Med"},{"issue":"6","key":"7842_CR37","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1152\/ajpendo.00158.2022","volume":"323","author":"P Sadana","year":"2022","unstructured":"Sadana P, Edler M, Aghayev M, Arias-Alvarado A, Cohn E, Ilchenko S, Piontkivska H, Pillai JA, Kashyap S, Kasumov T. Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice. Am J Physiol Endocrinol Metabolism. 2022;323(6):E480\u201391.","journal-title":"Am J Physiol Endocrinol Metabolism"},{"key":"7842_CR38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.schres.2017.10.042","volume":"197","author":"PB Gjerde","year":"2018","unstructured":"Gjerde PB, Dieset I, Simonsen C, Hoseth EZ, Iversen T, Lagerberg TV, Lyngstad SH, M\u00f8rch RH, Skrede S, Andreassen OA, et al. Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis. Schizophr Res. 2018;197:253\u201360.","journal-title":"Schizophr Res"},{"key":"7842_CR39","doi-asserted-by":"crossref","unstructured":"Cheng N, Ma H, Zhang K, Zhang C, Geng D. The predictive value of monocyte\/high-density lipoprotein ratio (MHR) and positive symptom scores for aggression in patients with schizophrenia. Med (Kaunas Lithuania). 2023;59(3).","DOI":"10.3390\/medicina59030503"},{"issue":"2","key":"7842_CR40","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1038\/tp.2016.278","volume":"7","author":"OD Howes","year":"2017","unstructured":"Howes OD, McCutcheon R. Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Translational Psychiatry. 2017;7(2):e1024.","journal-title":"Translational Psychiatry"},{"issue":"3","key":"7842_CR41","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1007\/s12035-024-04477-x","volume":"62","author":"CX Xu","year":"2025","unstructured":"Xu CX, Huang W, Shi XJ, Du Y, Liang JQ, Fang X, Chen HY, Cheng Y. Dysregulation of serum Exosomal lipid metabolism in schizophrenia: A biomarker perspective. Mol Neurobiol. 2025;62(3):3556\u201367.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"7842_CR42","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1038\/s41598-020-72934-3","volume":"10","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wu K, Li H, Zhou J, Xiong D, Huang X, Li J, Liu Y, Pan Z, Mitchell DT, et al. Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia. Sci Rep. 2020;10(1):16119.","journal-title":"Sci Rep"},{"key":"7842_CR43","doi-asserted-by":"crossref","first-page":"941728","DOI":"10.3389\/fpsyt.2022.941728","volume":"13","author":"Y Wei","year":"2022","unstructured":"Wei Y, Wang T, Li G, Feng J, Deng L, Xu H, Yin L, Ma J, Chen D, Chen J. Investigation of systemic immune-inflammation index, neutrophil\/high-density lipoprotein ratio, lymphocyte\/high-density lipoprotein ratio, and monocyte\/high-density lipoprotein ratio as indicators of inflammation in patients with schizophrenia and bipolar disorder. Front Psychiatry. 2022;13:941728.","journal-title":"Front Psychiatry"},{"key":"7842_CR44","doi-asserted-by":"crossref","unstructured":"Owusu-Ansah A, Berko Panyin A, Obirikorang C, Agyare C, Acheampong E, Kwofie S, Odame Anto E, Nsenbah Batu E. Metabolic syndrome among schizophrenic patients: a comparative cross-sectional study in the middle belt of Ghana. Schizophrenia Rese Treatment. 2018;2018:6542983.","DOI":"10.1155\/2018\/6542983"},{"key":"7842_CR45","doi-asserted-by":"crossref","first-page":"100245","DOI":"10.1016\/j.scog.2022.100245","volume":"28","author":"F Cuoco","year":"2022","unstructured":"Cuoco F, Agostoni G, Lesmo S, Sapienza J, Buonocore M, Bechi M, Martini F, Ferri I, Spangaro M, Bigai G, et al. Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: effects on cognition and quality of life. Schizophrenia Res Cognition. 2022;28:100245.","journal-title":"Schizophrenia Res Cognition"},{"issue":"3","key":"7842_CR46","first-page":"546","volume":"43","author":"J Firth","year":"2017","unstructured":"Firth J, Stubbs B, Rosenbaum S, Vancampfort D, Malchow B, Schuch F, Elliott R, Nuechterlein KH, Yung AR. Aerobic exercise improves cognitive functioning in people with schizophrenia: A systematic review and Meta-Analysis. Schizophr Bull. 2017;43(3):546\u201356.","journal-title":"Schizophr Bull"},{"issue":"4","key":"7842_CR47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.62641\/aep.v53i4.1854","volume":"53","author":"G Agostoni","year":"2025","unstructured":"Agostoni G, Repaci F, Bechi M, Calzavara Pinton I, Buonocore M, Spangaro M, Sapienza J, Martini F, D\u2019Antoni E, Giglio B, et al. Two is better than one: potentiating cognitive remediation with aerobic exercise to improve cognition in schizophrenia with a randomized controlled trial. Actas Esp De Psiquiatria. 2025;53(4):648\u201357.","journal-title":"Actas Esp De Psiquiatria"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-07842-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-07842-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:56:23Z","timestamp":1771422983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-07842-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7842"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-07842-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"11 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Review Committee of the Third People\u2019s Hospital of Foshan (Ethics approval number: FSSY-LS202411). Written informed consent was obtained from all participants or their legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}